A2A NEWS

January 22, 2019

PRESS RELEASE - A2A Pharmaceuticals Announces Fourth Quarter and Year End Results; Provides Business Update

November 05, 2018

A2A was a Finalist at RESI NYC Tech Hub Pitch Challenge

October 25, 2018

A2A Participated at the AI Applications Summit Biopharma Discussing the Urgency to Advance AI Applications in Industry to Bring Benefits to Patients Faster

October 18, 2018

A2A Founder & CEO Edward Painter was a Panelist at BIO Investor Forum Panel Entitled "Applying Artificial Intelligence to Improve Therapy Development Today"

July 20, 2018

Fierce Biotech: Insilico and A2A Launch New Duchenne-Focused AI Drug Company

July 05, 2018

PRESS RELEASE - A2A Pharma Provides Second Quarter 2018 Update

June 21, 2018

PRESS RELEASE - A2A Pharmaceuticals Takes Residency at JLABS@NYC

February 06, 2018

PRESS RELEASE - A2A Pharmaceuticals Investments Completed

December 12, 2017

A2A Wins AI Quickfire Challenge at JLABS @ Toronto

February 27, 2017

Irish Tech News - Innovative new biotechnologies showcased; IndieBio Demo Day reviewed

January 24, 2017

IndieBio - Designing Drugs In Silico: An Interview With Ed Painter of A2A Pharmaceuticals